Cargando…

Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice

BACKGROUND: Airborne allergens can induce an immunological chronic disease characterized by airway hyper responsiveness and inflammation, mediated by exaggerated Th2 immune response. Allergen-specific immunotherapy (AIT) is effective for treating this condition because it is able to modify its natur...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrarca, Claudia, Clemente, Emanuela, Amato, Valentina, Gatta, Alessia, Cortese, Sara, Lamolinara, Alessia, Rossi, Cosmo, Zanotta, Stefania, Mistrello, Gianni, Paganelli, Roberto, Di Gioacchino, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975903/
https://www.ncbi.nlm.nih.gov/pubmed/27499704
http://dx.doi.org/10.1186/s12948-016-0044-1
_version_ 1782446796216205312
author Petrarca, Claudia
Clemente, Emanuela
Amato, Valentina
Gatta, Alessia
Cortese, Sara
Lamolinara, Alessia
Rossi, Cosmo
Zanotta, Stefania
Mistrello, Gianni
Paganelli, Roberto
Di Gioacchino, Mario
author_facet Petrarca, Claudia
Clemente, Emanuela
Amato, Valentina
Gatta, Alessia
Cortese, Sara
Lamolinara, Alessia
Rossi, Cosmo
Zanotta, Stefania
Mistrello, Gianni
Paganelli, Roberto
Di Gioacchino, Mario
author_sort Petrarca, Claudia
collection PubMed
description BACKGROUND: Airborne allergens can induce an immunological chronic disease characterized by airway hyper responsiveness and inflammation, mediated by exaggerated Th2 immune response. Allergen-specific immunotherapy (AIT) is effective for treating this condition because it is able to modify its natural course by opposing the underlying pathogenic mechanisms and determining immune suppression, immune deviation and tolerance. The rational for the present study was to investigate the possibility of improving allergoid-based IT in terms of efficacy and safety. Recently, 1α,25-dihydroxyvitamin D(3) (VD(3)), the active metabolite of vitamin D(3), was described to be a potent inducer of T regulatory cells and to be a good adjuvant in AIT settings. METHODS: We investigated whether the co-administration of VD(3) could potentiate the effect of AIT even when added to a low dose of chemically-modified monomeric allergoid of Der p 2 (d2-OID), in a Derp p 2 (d2)-sensitized BALB/c mice model. Control groups where treated with sham, VD(3) alone or d2-OID only. RESULTS: The d2-OID alone was not fully successful, as expected for a low dose. VD(3) administration was associated with some valuable, although limited, changes in the immunological parameters in the lung. On the contrary, the VD(3) adjuvated allergoid vaccine induced the most prominent reduction of airway eosinophilia and Th2 cytokines and concomitant increase of T regulatory cells and IL-10 in the lung and Der p 2-specific IgG2a in the serum. CONCLUSIONS: The addition of VD(3) to a conventional AIT protocol would allow the reduction of allergoid dose needed and therefore, the production costs. Moreover, beneficial immunomodulatory effects have been achieved by the oral administration which might favour the management of the therapy by the patients and their adherence, possibly enhancing the efficacy of the treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12948-016-0044-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4975903
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49759032016-08-07 Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice Petrarca, Claudia Clemente, Emanuela Amato, Valentina Gatta, Alessia Cortese, Sara Lamolinara, Alessia Rossi, Cosmo Zanotta, Stefania Mistrello, Gianni Paganelli, Roberto Di Gioacchino, Mario Clin Mol Allergy Research BACKGROUND: Airborne allergens can induce an immunological chronic disease characterized by airway hyper responsiveness and inflammation, mediated by exaggerated Th2 immune response. Allergen-specific immunotherapy (AIT) is effective for treating this condition because it is able to modify its natural course by opposing the underlying pathogenic mechanisms and determining immune suppression, immune deviation and tolerance. The rational for the present study was to investigate the possibility of improving allergoid-based IT in terms of efficacy and safety. Recently, 1α,25-dihydroxyvitamin D(3) (VD(3)), the active metabolite of vitamin D(3), was described to be a potent inducer of T regulatory cells and to be a good adjuvant in AIT settings. METHODS: We investigated whether the co-administration of VD(3) could potentiate the effect of AIT even when added to a low dose of chemically-modified monomeric allergoid of Der p 2 (d2-OID), in a Derp p 2 (d2)-sensitized BALB/c mice model. Control groups where treated with sham, VD(3) alone or d2-OID only. RESULTS: The d2-OID alone was not fully successful, as expected for a low dose. VD(3) administration was associated with some valuable, although limited, changes in the immunological parameters in the lung. On the contrary, the VD(3) adjuvated allergoid vaccine induced the most prominent reduction of airway eosinophilia and Th2 cytokines and concomitant increase of T regulatory cells and IL-10 in the lung and Der p 2-specific IgG2a in the serum. CONCLUSIONS: The addition of VD(3) to a conventional AIT protocol would allow the reduction of allergoid dose needed and therefore, the production costs. Moreover, beneficial immunomodulatory effects have been achieved by the oral administration which might favour the management of the therapy by the patients and their adherence, possibly enhancing the efficacy of the treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12948-016-0044-1) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-05 /pmc/articles/PMC4975903/ /pubmed/27499704 http://dx.doi.org/10.1186/s12948-016-0044-1 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Petrarca, Claudia
Clemente, Emanuela
Amato, Valentina
Gatta, Alessia
Cortese, Sara
Lamolinara, Alessia
Rossi, Cosmo
Zanotta, Stefania
Mistrello, Gianni
Paganelli, Roberto
Di Gioacchino, Mario
Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice
title Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice
title_full Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice
title_fullStr Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice
title_full_unstemmed Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice
title_short Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice
title_sort vitamin d3 improves the effects of low dose der p 2 allergoid treatment in der p 2 sensitized balb/c mice
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975903/
https://www.ncbi.nlm.nih.gov/pubmed/27499704
http://dx.doi.org/10.1186/s12948-016-0044-1
work_keys_str_mv AT petrarcaclaudia vitamind3improvestheeffectsoflowdosederp2allergoidtreatmentinderp2sensitizedbalbcmice
AT clementeemanuela vitamind3improvestheeffectsoflowdosederp2allergoidtreatmentinderp2sensitizedbalbcmice
AT amatovalentina vitamind3improvestheeffectsoflowdosederp2allergoidtreatmentinderp2sensitizedbalbcmice
AT gattaalessia vitamind3improvestheeffectsoflowdosederp2allergoidtreatmentinderp2sensitizedbalbcmice
AT cortesesara vitamind3improvestheeffectsoflowdosederp2allergoidtreatmentinderp2sensitizedbalbcmice
AT lamolinaraalessia vitamind3improvestheeffectsoflowdosederp2allergoidtreatmentinderp2sensitizedbalbcmice
AT rossicosmo vitamind3improvestheeffectsoflowdosederp2allergoidtreatmentinderp2sensitizedbalbcmice
AT zanottastefania vitamind3improvestheeffectsoflowdosederp2allergoidtreatmentinderp2sensitizedbalbcmice
AT mistrellogianni vitamind3improvestheeffectsoflowdosederp2allergoidtreatmentinderp2sensitizedbalbcmice
AT paganelliroberto vitamind3improvestheeffectsoflowdosederp2allergoidtreatmentinderp2sensitizedbalbcmice
AT digioacchinomario vitamind3improvestheeffectsoflowdosederp2allergoidtreatmentinderp2sensitizedbalbcmice